Shilpa Medicare
Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
DitchCarbon Score
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shilpa Medicare's score of 27 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shilpa Medicare's reported carbon emissions
In 2023, Shilpa Medicare reported total carbon emissions of approximately 15,232,800 kg CO2e, comprising 1,523,280 kg CO2e from Scope 1 and 14,691,660 kg CO2e from Scope 2 emissions. Additionally, Scope 3 emissions were recorded at about 710,410 kg CO2e. The company has shown a significant increase in emissions compared to previous years, with 2022 emissions at approximately 15,169,700 kg CO2e, including 1,516,970 kg CO2e from Scope 1 and 15,503,870 kg CO2e from Scope 2, alongside 877,770 kg CO2e from Scope 3. In 2024, emissions further escalated to about 20,389,900 kg CO2e in Scope 2 and 3,690,310 kg CO2e in Scope 1, indicating a trend of rising emissions. Currently, Shilpa Medicare has not established specific reduction targets or climate pledges, which may reflect a broader industry context where many companies are still developing their climate strategies. The absence of documented reduction initiatives suggests an opportunity for the company to enhance its climate commitments and align with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,516,970 | 0,000,000 | 0,000,000 |
| Scope 2 | 15,503,870 | 00,000,000 | 00,000,000 |
| Scope 3 | 877,770 | 000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shilpa Medicare is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
